Teprenone

Teprenone

Clinical data
Trade names	Selbex
AHFS/Drugs.com	International Drug Names
ATC code	A02BX15 (WHO) QA02BX15 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
CAS Number	6809-52-5
PubChem CID	5282199
DrugBank	DB15955^Y
ChemSpider	29787024
UNII	S8S8451A4O
KEGG	D01827^Y
ChEBI	CHEBI:31649
ChEMBL	ChEMBL79686
CompTox Dashboard (EPA)	DTXSID901166719
Chemical and physical data
Formula	C23H38O
Molar mass	330.556 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O
InChI InChI=1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3/b20-13+,21-15+,22-17+ Key:HUCXKZBETONXFO-NJFMWZAGSA-N
(verify)

Teprenone (or geranylgeranylacetone), sold under the brand name Selbex,[1] is a medication used for the treatment of gastric ulcers.[2]

References

1. Liu X, Jia B, Lin S (January 1996). "[Teprenone in the treatment of chronic superficial gastritis, a multicentre study]". Zhonghua Nei Ke Za Zhi (in Chinese). 35 (1): 12–4. PMID 9275638.
2. Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879. S2CID 19387865.